Cumulative Prognostic Benefit of Classical Cardiovascular Risk Factors

Copyright © 2009 American Heart Association. All rights reserved. Print ISSN: 1941-3289. Online Dallas, TX 72514 Circulation: Heart Failure is published by the American Heart Association. 7272 Greenville Avenue, DOI: 10.1161/CIRCHEARTFAILURE.108.825059 2009;2;563-571; originally published online Sep 24, 2009; Circ Heart Fail Michael T. Koller, Georg Ertl, Christiane E. Angermann and Stefan Störk Gülmisal Güder, Stefan Frantz, Johann Bauersachs, Bruno Allolio, Christoph Wanner, Prognostic Benefit of Classical Cardiovascular Risk Factors Reverse Epidemiology in Systolic and Nonsystolic Heart Failure: Cumulative http://circheartfailure.ahajournals.org/cgi/content/full/2/6/563 located on the World Wide Web at: The online version of this article, along with updated information and services, is

[1]  C. Angermann,et al.  Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community‐based sample of patients with chronic heart failure A prospective cohort study , 2008, European journal of heart failure.

[2]  G. Fonarow,et al.  Nutritional and anti-inflammatory interventions in chronic heart failure. , 2008, The American journal of cardiology.

[3]  G. Fonarow,et al.  Albumin levels predict survival in patients with systolic heart failure. , 2008, American heart journal.

[4]  A. Jánosi,et al.  Rosuvastatin in older patients with systolic heart failure. , 2007, The New England journal of medicine.

[5]  J. Shanes,et al.  Statin therapy in heart failure: prognostic effects and potential mechanisms. , 2007, American heart journal.

[6]  G. Fonarow,et al.  CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Reverse Epidemiology beyond Dialysis Patients: Chronic Heart Failure, Geriatrics, Rheumatoid Arthritis, COPD, and AIDS , 2007, Seminars in dialysis.

[7]  Eduardo Lacson,et al.  CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: The Association between Blood Pressure and Mortality in ESRD—Not Different from the General Population? , 2007, Seminars in dialysis.

[8]  K. Kalantar-Zadeh,et al.  The kidney disease wasting: Inflammation, oxidative stress, and diet‐gene interaction , 2006, Hemodialysis international. International Symposium on Home Hemodialysis.

[9]  N. Lakkis,et al.  The obesity paradox: fact or fiction? , 2006, The American journal of cardiology.

[10]  Eduardo Lacson,et al.  The epidemiology of systolic blood pressure and death risk in hemodialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  P. Ponikowski,et al.  ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology. , 2006, Clinical nutrition.

[12]  W. März,et al.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.

[13]  K. Kalantar-Zadeh,et al.  Survival advantages of obesity in dialysis patients. , 2005, The American journal of clinical nutrition.

[14]  D. Pennell,et al.  Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study. , 2004, International Journal of Cardiology.

[15]  Kamyar Kalantar-Zadeh,et al.  Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. , 2004, Journal of the American College of Cardiology.

[16]  Doron Schwartz,et al.  The association between congestive heart failure and chronic renal disease , 2004, Current opinion in nephrology and hypertension.

[17]  H. Krumholz,et al.  The obesity paradox: body mass index and outcomes in patients with heart failure. , 2005, Archives of internal medicine.

[18]  M. Gheorghiade,et al.  Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach. , 2003, Italian heart journal : official journal of the Italian Federation of Cardiology.

[19]  D. Levy,et al.  Obesity and the risk of heart failure. , 2003, The New England journal of medicine.

[20]  P. Poole‐Wilson,et al.  Mode of death in heart failure: findings from the ATLAS trial , 2003, Heart.

[21]  G. Fonarow,et al.  Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. , 2002, Journal of cardiac failure.

[22]  G. Fonarow,et al.  The relationship between obesity and mortality in patients with heart failure. , 2001, Journal of the American College of Cardiology.

[23]  T. Cederholm,et al.  Treatment of protein-energy malnutrition in chronic nonmalignant disorders. , 2001, The American journal of clinical nutrition.

[24]  S. Anker,et al.  The endotoxin-lipoprotein hypothesis , 2000, The Lancet.

[25]  R F Anda,et al.  Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population. , 1999, Archives of internal medicine.

[26]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[27]  E. J. Benjamin,et al.  Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. , 1995, Journal of the American College of Cardiology.

[28]  A J Tajik,et al.  Two-Dimensional and Doppler Echocardiography Alone Can Adequately Define Preoperative Anatomy and Hemodynamic Status before Repair of Complete Atrioventricular Septal Defect in Infants <1 Year Old , 1994, Circulation.

[29]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[30]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[31]  L. Tavazzi,et al.  Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. , 2008, Lancet.

[32]  M. Cheitlin.  An obesity paradox in acute heart failure: Analysis of body mass index and inhospital mortality for 108 927 patients in the Acute Decompensated Heart Failure National Registry , 2008 .

[33]  G. Fonarow,et al.  An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. , 2007, American heart journal.

[34]  C. Lavie,et al.  Obesity and heart failure prognosis: paradox or reverse epidemiology? , 2005, European heart journal.

[35]  F. Harrell.  REGRESSION MODELING STRATEGIES WITH APPLICATION TO LOGISTIC REGRESSION , 2005 .

[36]  C. O'connor,et al.  Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. , 2003, American heart journal.

[37]  A. Rolnitzky,et al.  [Cardiac cachexia]. , 2000, Harefuah.

[38]  S. Coppack,et al.  Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. , 1999, The American journal of physiology.

[39]  C Safran,et al.  Serum albumin level on admission as a predictor of death, length of stay, and readmission. , 1992, Archives of internal medicine.